Responsibly Advancing the Use of AI in Clinical Trials: Current landscape, Common Misconceptions and Future Opportunities, Upcoming Webinar Hosted by Xtalks

Press Releases

Feb 01, 2024

In this free webinar, gain insights into AI’s transformative role in clinical trials, addressing industry status, misconceptions, bias and regulatory issues. Attendees will learn about AI’s impact on improving operations, patient privacy, data quality and reducing human error in clinical trials. The featured speakers will discuss ethical AI usage, focusing on data privacy and algorithm bias reduction.

TORONTO, Feb. 1, 2024 /PRNewswire-PRWeb/ — Discover an informative webinar delving into the transformative role of artificial intelligence (AI) in clinical trials: where the industry is currently at, common misconceptions in leveraging AI, proactively tackling the potential for bias and navigating the current regulatory landscape.

Following current regulatory guidance and a company code of conduct, AI, machine learning and deep learning capabilities are responsible across more than 600 ongoing, active clinical trials.

In its current state, AI can help optimize operations, integrate platforms, strengthen patient privacy and improve data quality while reducing the risk of human error in clinical trials. AI must be used responsibly and be governed by the highest ethical principles when used in clinical trials. This includes data privacy considerations, and efforts to reduce bias in algorithm performance. Following current regulatory guidance and a company code of conduct, AI, machine learning and deep learning capabilities are responsible across more than 600 ongoing, active clinical trials.

Register for this webinar to gain an understanding of the responsible application of AI-enabled algorithms in clinical trial endpoint collection and data analysis.

Join experts from Clario, Todd Rudo, MD, Chief Medical Officer; Lauren Misztal, Senior Vice President, General Counsel; and Gaurav Josan, Senior Vice President, R&D, for the live webinar on Thursday, February 22, 2024, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Responsibly Advancing the Use of AI in Clinical Trials: Current landscape, Common Misconceptions and Future Opportunities.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com

Cision View original content to download multimedia:https://www.prweb.com/releases/responsibly-advancing-the-use-of-ai-in-clinical-trials-current-landscape-common-misconceptions-and-future-opportunities-upcoming-webinar-hosted-by-xtalks-302050532.html

SOURCE Xtalks

YOU MAY ALSO LIKE

Peer Unveils a Groundbreaking Virtual Universe to…

In this free webinar, gain insights into AI's transformative role in clinical trials, addressing industry status, misconceptions, bias and regulatory issues. Attendees will learn about…

read more

Vantiq, Telemedicine Solutions and NTT DATA Announce…

In this free webinar, gain insights into AI's transformative role in clinical trials, addressing industry status, misconceptions, bias and regulatory issues. Attendees will learn about…

read more

Synthetic Identities and Deep Fakes: The New…

In this free webinar, gain insights into AI's transformative role in clinical trials, addressing industry status, misconceptions, bias and regulatory issues. Attendees will learn about…

read more